# Efficacy of Early Argipressin in the Management of Intensive Care Patients With Norepinephrine-refractory Vasoplegic Shock

> **NCT07063680** · PHASE3 · RECRUITING · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 390 (estimated)

## Conditions studied

- Patients With Norepinephrine-refractory Vasoplegic Shock

## Interventions

- **DRUG:** Argipressin
- **DRUG:** Chlorure de sodium
- **OTHER:** Collection of clinical data

## Key facts

- **NCT ID:** NCT07063680
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-07
- **Primary completion:** 2029-01
- **Final completion:** 2029-01
- **Target enrollment:** 390 (ESTIMATED)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07063680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07063680, "Efficacy of Early Argipressin in the Management of Intensive Care Patients With Norepinephrine-refractory Vasoplegic Shock". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07063680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*